UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION


                             Washington, D.C. 20549


                                    FORM 8-K

                                 CURRENT REPORT


     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934


                        Date of Report: November 14, 2007

                       (Date of earliest event reported):


                              INNODATA ISOGEN, INC.
             (Exact name of registrant as specified in its charter)


            Delaware                 0-22196               13-3475943
 (State or other jurisdiction      (Commission          (I.R.S. Employer
        of incorporation)          File Number)        Identification No.)



          Three University Plaza                             07601
            Hackensack, NJ 07601                           (Zip Code)
  (Address of principal executive offices)


                                 (201) 371-2828
              (Registrant's telephone number, including area code)

                                       N/A
          (Former name or former address, if changed since last report)


Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:

|_| Written communications pursuant to Rule 425 under the Securities Act (17 CFR
    230.425)

|_| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
    240.14a-12)

|_| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
    Act (17 CFR 240.14d-2(b))

|_| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
    Act (17 CFR 240.13e-4(c))






Item 2.02    Results of Operations and Financial Condition.
             ---------------------------------------------

     On November 14, 2007, Innodata Isogen, Inc. issued a press release
announcing its third quarter 2007 financial results. A copy of the press release
is attached hereto as Exhibit 99.1.

     In accordance with General Instruction B.2 of Form 8-K, the information in
this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed to
be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as
amended (the "Exchange Act"), or otherwise subject to the liability of that
section, and shall not be incorporated by reference into any registration
statement or other document filed under the Securities Act of 1933, as amended,
or the Exchange Act, except as shall be expressly set forth by specific
reference in such filing.


Item 9.01    Financial Statements and Exhibits.
             ---------------------------------

99.1         Press release dated November 14, 2007.



                                       2



                                   SIGNATURES
                                   ----------

     Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.

                                               INNODATA ISOGEN, INC.



Date: November 14, 2007                        By:  /s/ Steven L. Ford
                                                   -----------------------------
                                                    Steven L. Ford
                                                    Executive Vice President
                                                    and Chief Financial Officer



                                       3



                                INDEX TO EXHIBITS
                                -----------------


 Exhibit No.                               Description

     99.1        Press Release of Innodata Isogen, Inc., dated November 14,
                 2007, reporting third quarter 2007 financial results.



                                       4